OVIT (OncoVista Innovative Therapies) EV-to-FCF : 0.00 (As of Sep. 21, 2024)

OncoVista Innovative Therapies EV-to-FCF Chart

OncoVista Innovative Therapies Annual Data
	Trend	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14
EV-to-FCF		Get a 7-Day Free Trial					-6.49	-3.43	-1.48	-2.22	-6.53

OncoVista Innovative Therapies Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
EV-to-FCF	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of OncoVista Innovative Therapies's EV-to-FCF

For the Biotechnology subindustry, OncoVista Innovative Therapies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoVista Innovative Therapies's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoVista Innovative Therapies's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where OncoVista Innovative Therapies's EV-to-FCF falls into.

OncoVista Innovative Therapies EV-to-FCF Calculation

OncoVista Innovative Therapies's EV-to-FCF for today is calculated as:

OncoVista Innovative Therapies's current Enterprise Value is $0.00 Mil.
OncoVista Innovative Therapies's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies  (OTCPK:OVIT) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

OncoVista Innovative Therapies's PE Ratio for today is calculated as:

OncoVista Innovative Therapies's share price for today is $0.0001.
OncoVista Innovative Therapies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.140.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

OncoVista Innovative Therapies EV-to-FCF Related Terms

Thank you for viewing the detailed overview of OncoVista Innovative Therapies's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoVista Innovative Therapies Business Description